Independent elevations of N-terminal pro–brain natriuretic peptide and cardiac troponins in endurance athletes after prolonged strenuous exercise

Maisel, 2001, B-type natriuretic peptide levels: a potential novel “white count” for congestive heart failure, J Card Fail, 7, 183, 10.1054/jcaf.2001.24609 Hall, 2004, Essential biochemistry and physiology of (NT-pro) BNP, Eur J Heart Fail, 6, 257, 10.1016/j.ejheart.2003.12.015 Lubien, 2002, Utility of B-natriuretic peptide in detecting diastolic dysfunction, Circulation, 105, 595, 10.1161/hc0502.103010 Almeida, 2002, B-type natriuretic peptide is related to left ventricular mass in hypertensive patients but not in athletes, Cardiology, 98, 113, 10.1159/000066319 Mizuno Y, Yoshimura M, Harada E et al. Plasma levels of A- and B-type natriuretic peptides in patients with hypertrophic cardiomyopathy or idiopathic dilated cardiomyopathy. Am J Cardiol 2000;86:1036-40, A11. Jernberg, 2002, N-terminal pro brain natriuretic peptide on admission for early risk stratification of patients with chest pain and no ST-segment elevation, J Am Coll Cardiol, 40, 437, 10.1016/S0735-1097(02)01986-1 Tulevski, 2001, Increased brain natriuretic peptide as a marker for right ventricular dysfunction in acute pulmonary embolism, Thromb Haemost, 86, 1193, 10.1055/s-0037-1616050 Scharhag, 2004, No difference in N-terminal pro-brain natriuretic peptide (NT-proBNP) concentrations between endurance athletes with athlete's heart and healthy untrained controls, Heart, 90, 1055, 10.1136/hrt.2003.020420 Herrmann, 2003, Post-race kinetics of cardiac troponin T and I and N-terminal pro-brain natriuretic peptide in marathon runners, Clin Chem, 49, 831, 10.1373/49.5.831 Ohba, 2001, Effects of prolonged strenuous exercise on plasma levels of atrial natriuretic peptide and brain natriuretic peptide in healthy men, Am Heart J, 141, 751, 10.1067/mhj.2001.114371 Apple, 2003, Plasma 99th percentile reference limits for cardiac troponin and creatine kinase MB mass for use with European Society of Cardiology/American College of Cardiology consensus recommendations, Clin Chem, 49, 1331, 10.1373/49.8.1331 Tanaka, 1995, Exercise-induced secretion of brain natriuretic peptide in essential hypertension and normal subjects, Hypertens Res, 18, 159, 10.1291/hypres.18.159 Troughton, 2000, Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations, Lancet, 355, 1126, 10.1016/S0140-6736(00)02060-2 D'Souza, 2003, B type natriuretic peptide: a good omen in myocardial ischemia?, Heart, 89, 707, 10.1136/heart.89.7.707 Wiese, 2000, Gene expression of brain natriuretic peptide in isolated atrial and ventricular human myocardium: influence of angiotensin II and diastolic fiber length, Circulation, 102, 3074, 10.1161/01.CIR.102.25.3074 Kindermann, 1974, Principles of the evaluation of achievement—physiological adaptation, Dtsch Med Wochenschr, 99, 1372, 10.1055/s-0028-1107950 Wiese, 1998, Induction of BNP expression in human myocardium by angiotensin, catecholamines and diastolic stretch. 6th World Congress on Heart Failure, J Heart Fail D'Souza, 2003, B-type natriuretic peptide limits infarct size in rat isolated hearts via KATP channel opening, Am J Physiol Heart Circ Physiol, 284, H1592, 10.1152/ajpheart.00902.2002 Baxter, 2004, Natriuretic peptides and myocardial ischemia, Basic Res Cardiol, 99, 30 Brunner-La Rocca, 2001, Effects of intravenous brain natriuretic peptide on regional sympathetic activity in patients with chronic heart failure as compared with healthy control subjects, J Am Coll Cardiol, 37, 1221, 10.1016/S0735-1097(01)01172-X Filippatos, 2001, Regulation of apoptosis by vasoactive peptides, Am J Physiol Lung Cell Mol Physiol, 281, L749, 10.1152/ajplung.2001.281.4.L749 Tamura, 2000, Cardiac fibrosis in mice lacking brain natriuretic peptide, Proc Natl Acad Sci U S A, 97, 4239, 10.1073/pnas.070371497 Kuhn, 2002, Progressive cardiac hypertrophy and dysfunction in atrial natriuretic peptide receptor (GC-A) deficient mice, Heart, 87, 368, 10.1136/heart.87.4.368 Montgomery, 1997, Association of angiotensin-converting enzyme gene I/D polymorphism with change in left ventricular mass in response to physical training, Circulation, 96, 741, 10.1161/01.CIR.96.3.741 Apple, 2002, European Society of Cardiology and American College of Cardiology guidelines for redefinition of myocardial infarction: how to use existing assays clinically and for clinical trials, Am Heart J, 144, 981, 10.1067/mhj.2002.124048 Apple, 2002, Release characteristics of cardiac biomarkers and ischemia-modified albumin as measured by the albumin cobalt-binding test after a marathon race, Clin Chem, 48, 1097, 10.1093/clinchem/48.7.1097 Koller, 1999, Regular exercise and subclinical myocardial injury during prolonged aerobic exercise, JAMA, 282, 1816, 10.1001/jama.282.19.1816 Neumayr, 2002, Effect of the “Race across the Alps” in elite cyclists on plasma cardiac troponins I and T, Am J Cardiol, 89, 484, 10.1016/S0002-9149(01)02280-9 Shave, 2002, Evidence of exercise-induced cardiac dysfunction and elevated cTnT in separate cohorts competing in an ultra-endurance mountain marathon race, Int J Sports Med, 23, 489, 10.1055/s-2002-35069 Siegel, 2001, Changes in cardiac markers including B-natriuretic peptide in runners after the Boston marathon, Am J Cardiol, 88, 920, 10.1016/S0002-9149(01)01910-5 Shave, 2004, Altered cardiac function and minimal cardiac damage during prolonged exercise, Med Sci Sports Exerc, 36, 1098, 10.1249/01.MSS.0000131958.18154.1E George, 2004, Postexercise left ventricular function and cTnT in recreational marathon runners, Med Sci Sports Exerc, 36, 1709, 10.1249/01.MSS.0000142408.05337.49 Urhausen, 2004, Clinical significance of increased cardiac troponin T and I in participants of ultra-endurance events, Am J Cardiol, 94, 696, 10.1016/j.amjcard.2004.05.050 Wu, 1999, Release of cardiac troponin in acute coronary syndromes: ischemia or necrosis?, Clin Chim Acta, 284, 161, 10.1016/S0009-8981(99)00078-9 Bakshi, 2002, Causes of elevated troponin I with a normal coronary angiogram, Int J Med, 32, 520, 10.1046/j.1445-5994.2002.00270.x La Gerche, 2004, No evidence of sustained myocardial injury following an iron man distance triathlon, Int J Sports Med, 25, 45, 10.1055/s-2003-45236